Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 617-619 , November 2009

Geriatric urologic oncology: A field coming of age

References 

  1. Linder FE, Grove RD. Vital Statistics Rates in the United States, 1900–1940. Washington, DC: Government Printing Office; 1947;
  2. Hollmann FW. Current Population Reports: Population Estimates and Projections, Series P-25, No. 1057 (US Population Estimates by Age, Sex, Race, and Hispanic Origin: 1989). Washington, DC: US Bureau of the Census, Government Printing Office; March 1990;
  3. He W, Sengupta M, Velkoff V, et al. US Census Bureau: 65+ in the United States. US Government Printing Office, Current Population Report P23-209, Washington DC: 2005.
  4. Torrey BB, Kinsella K, Taeuber CM. An Aging World (International Population Reports, Series P-95, No. 78). Washington, DC: US Bureau of the Census; 1987;
  5. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review: 1975–2003.
  6. Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med. 2002;346:905–912
  7. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–252
  8. Hutchins LF, Unger JM, Crowley JJ, et al. Under-representation of patients 65 years of age or older in cancer treatment trials. N Engl J Med. 1999;341:2061–2067
  9. Yee KW, Pater JL, Pho L, et al. Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?. J Clin Oncol. 2003;21:1618–1623
  10. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22:4626–4631
  11. Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–1587
  12. Dixon DO, Neilan B, Jones S, et al. Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: The Southwest Oncology Group experience. J Clin Oncol. 1986;4:295–305

PII: S1078-1439(09)00213-0

doi: 10.1016/j.urolonc.2009.07.012

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 617-619 , November 2009

Article Tools